Candidature YC de Atomic Alchemy

Winter 2019Acquired

Atomic Alchemy a été sélectionné par Y Combinator dans le cadre du batch Winter 2019 en tant qu'entreprise Industrials. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC: Winter 2019
Secteur d'activité: IndustrialsManufacturing and Robotics
Taille de l'équipe: 8
Statut: Acquired
Lancé: 2018

Fondateurs

Thomas EidenFounder

Ce que fait Atomic Alchemy

Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments. Currently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine procedures, is sourced from just six government-run, scientific research reactors abroad. Five of these reactors are 45-65 years old and are quickly coming to the end of their operational life. This has cultivated a fragile and lengthy supply chain, at odds with the nature of radioactive material. This issue and its implications do not just effect molybdenum, but any other reactor-based isotope. Many promising cancer therapies are stuck in clinical trials, unable to secure enough material in a timely manner. Research doesn’t even happen because of the difficulty of sourcing any new isotopes. It doesn't have to be this way. Atomic Alchemy is working to solve this by building the world's first scalable radioisotope production facility. This facility will contain the world’s first privately-owned nuclear reactors dedicated to radioisotope production.

Candidature YC de Atomic Alchemy, reconstruite

Candidature Y Combinator

Atomic Alchemy, promotion Winter 2019. Les vraies questions de candidature, répondues à partir de données publiques.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Atomic Alchemy

Describe what your company does in 50 characters or less.

Cancer-curing materials for nuclear medicine

What is your company going to make? Please describe your product and what it does or will do.

We build and operate modular nuclear reactors dedicated to producing radioisotopes used in medical diagnostics and cancer treatments. Our product is a scalable facility that supplies reliable isotopes like Molybdenum-99, critical for 80% of nuclear medicine procedures, improving the fragile global supply chain.

Where do you live now, and where would the company be based after YC?

We live in Idaho Falls, ID where the company is also based.

Explain your decision regarding location.

Idaho Falls is close to the Idaho National Laboratory and other nuclear facilities, giving us access to talent and infrastructure specialized for nuclear technology development and isotope production.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Voir la candidature complète

Questions fréquemment posées

Est-ce la vraie candidature YC de Atomic Alchemy ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Atomic Alchemy (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Atomic Alchemy se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC Atomic Alchemy appartenait-il ?

Atomic Alchemy faisait partie du batch Winter 2019 de Y Combinator.

Qui a fondé Atomic Alchemy ?

Atomic Alchemy a été fondé par Thomas Eiden.

Que fait Atomic Alchemy ?

We produce cancer-curing materials used in nuclear medicine.

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de Atomic Alchemy en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.